Vaccines Developed Throughout the World

Each vaccine developed throughout the world to combat the spread of the Novel coronavirus must go through a clinical study. As previously stated, ten vaccinations were provided as part of the COVID Suraksha mission, but only a handful of them made it to the human trials stage.

This is to guarantee that the medicine is safe for therapeutic reasons and will not harm the patients. The following COVID vaccines have successfully advanced to the human testing stage: 

1. Sputnik V

• Sputnik V is the first vaccination to be authorized and ready for use, named after the first artificial Earth satellite, Sputnik-I.
• Russia registered the vaccination. 

2. Covaxin

• It is an Indian vaccine developed in conjunction with the Indian Council of Medical Research by Bharat Biotech (ICMR).

3. ZyCoV-D

• This Indian vaccine was created by the pharmaceutical company Zydus.
• This vaccine was created in collaboration with the Department of Biotechnology’s National Biopharma Mission (DBT).

4. BNT162b2

• It is an mRNA vaccine
• Pfizer, an American pharmaceutical corporation, created this COVID-19 vaccine.
• It is one of the only vaccinations that has shown to be nearly effective in preventing COVID.
• Pfizer was able to complete all of the trials and begin commercial distribution within a few months after its development.

Apart from those described above, a few more COVID-19 vaccine candidates that have not fared well are listed below:

1. Oxford University’s AZD1222
2. Beijing Institute of Biotechnology developed Ad5-nCoV.
3. Johnson & Johnson ad 26.COV2.S
4. Government of Canada and Quebec CoVLPs 

The World Health Organization has overseen all operations related to the transmission of the Wuhan coronavirus, including vaccinations and safeguards (WHO). 

The Indian government-sponsored “Mission COVID Suraksha,” a training program for Indian candidates and researchers working on the COVID-19 vaccine. The government will support the clinical research, production, and licensing of Indian vaccinations to combat the viral attack under this goal. The Mission was designed to be a National Mission to bring to the citizens of the country should be given a safe, effective, economical, and easily available COVID-19 vaccine as soon as possible, with an emphasis on AtmaNirbhar Bharat. The Mission’s purpose is to accelerate the creation of at least 5 to 6 COVID-19 vaccine candidates, with some of these being clinically tested and brought closer to licensing and market debut for regulatory consideration authority, as well as for implementation in public health systems. In this post, we will go over the funds set aside for this mission, as well as the goals and COVID vaccines being produced in India. This is especially significant in light of the approaching Government and Administrative examinations.